Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

Fiona Powrie © Thomas S. G. Farnetti Wellcome

Wellcome is a global charitable foundation that funds thousands of researchers. It works with academia, philanthropy, businesses, governments, civil society and the public around the world to support science's role in solving health challenges.

With a background in immunology and translational research, Fiona has been a member of Wellcome's Board of Governors since January 2018. She will take up her post in January 2022 from Professor Mike Ferguson, who is stepping down from the Board and Wellcome after 10 years.

Following her appointment, Fiona said: "It is an honour and privilege to serve Wellcome as Deputy Chair. It's an organisation that I've always admired from the beginning of my career. I look forward to working with everyone at Wellcome to help deliver our new strategy that harnesses science and research to improve health for all."

Commenting on her appointment, Julia Gillard, Chair of Wellcome, said: "Fiona's new role as Deputy Chair will allow us to benefit even more from her experience in science and research. I look forward to working with her to drive forward Wellcome's mission to solve the urgent health challenges facing everyone."

Professor Andrew Carr, Head of Department at NDORMS, University of Oxford said: "We send our warm congratulations to Fiona on this new appointment. Fiona's pioneering work in immunology has contributed to a better understanding, prevention and treatment of disease which will help advance global scientific discovery research at Wellcome."

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.